UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

A review of analytical methods for the determination of four new phosphodiesterase type 5 inhibitors in biological samples and pharmaceutical preparations

Brazilian Journal of Pharmaceutical Sciences, 2013-03, Vol.49 (1), p.1-11

2013

Link zum Volltext

Verfügbarkeit prüfen

Effects of obstructive sleep apnea and its treatment over the erectile function： a systematic review

Asian journal of andrology, 2017-05, Vol.19 (3), p.303-310

2017

Link zum Volltext

Verfügbarkeit prüfen

Twelve-Month Efficacy and Safety of Low-Intensity Shockwave Therapy for Erectile Dysfunction in Patients Who Do Not Respond to Phosphodiesterase Type 5 Inhibitors

Sexual medicine, 2016-12, Vol.4 (4), p.e225-e232

2016

Link zum Volltext

Verfügbarkeit prüfen

A meta-regression evaluating the effectiveness and prognostic factors of oral phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction

Asian journal of andrology, 2016-01, Vol.18 (1), p.60-65

2016

Link zum Volltext

Verfügbarkeit prüfen

The NO/cGMP/PKG pathway in platelets: The therapeutic potential of PDE5 inhibitors in platelet disorders

Journal of thrombosis and haemostasis, 2022-11, Vol.20 (11), p.2465-2474

2022

Link zum Volltext

Verfügbarkeit prüfen

Successful treatment of pulmonary hypertension following hematopoietic stem cell transplant with a single oral tadalafil: a case report

Pulmonary circulation, 2021-07, Vol.11 (3), p.1-5

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction

Asian journal of andrology, 2015-01, Vol.17 (1), p.143-148

2015

Link zum Volltext

Verfügbarkeit prüfen

Demographics and sexual characteristics of sex-enhancing medication users: Study of a web-based cross-sectional sample of sexually active men

Arab Journal of Urology, 2017-12, Vol.15 (4), p.366-371

2017

Link zum Volltext

Verfügbarkeit prüfen

Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons

Arab Journal of Urology, 2013-09, Vol.11 (3), p.222-229

2013

Link zum Volltext

Verfügbarkeit prüfen

Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015)

Journal of sexual medicine, 2016-04, Vol.13 (4), p.465-488

2016

Link zum Volltext

Verfügbarkeit prüfen

Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

European urology, 2016-07, Vol.70 (1), p.124-133

2016

Link zum Volltext

Verfügbarkeit prüfen

A Systematic Review of the Association Between Erectile Dysfunction and Cardiovascular Disease

European urology, 2014-05, Vol.65 (5), p.968-978

2014

Link zum Volltext

Verfügbarkeit prüfen

Management of Pulmonary Arterial Hypertension

Journal of the American College of Cardiology, 2015-05, Vol.65 (18), p.1976-1997

2015

Link zum Volltext

Verfügbarkeit prüfen

Sexual life of Japanese patients with erectile dysfunction taking phosphodiesterase type 5 inhibitors: An Internet survey using the Psychological and Interpersonal Relationship Scales-Short Form questionnaire

International journal of urology, 2014-08, Vol.21 (8), p.821-825

2014

Link zum Volltext

Verfügbarkeit prüfen

Management of Benign Prostatic Hyperplasia

Annual review of medicine, 2016-01, Vol.67 (1), p.137-151

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparative Effectiveness and Safety of Oral Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction: A Systematic Review and Network Meta-analysis

European urology, 2013-05, Vol.63 (5), p.902-912

2013

Link zum Volltext

Verfügbarkeit prüfen

The Mechanism of Action of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia

European urology, 2013-03, Vol.63 (3), p.506-516

2013

Link zum Volltext

Verfügbarkeit prüfen

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)

European heart journal, 2016-01, Vol.37 (1), p.67-119

2016

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Safety of Ambrisentan in Combination With Sildenafil in Healthy Volunteers

Journal of clinical pharmacology, 2008-12, Vol.48 (12), p.1451-1459

2008

Link zum Volltext

Verfügbarkeit prüfen

Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health

Journal of sexual medicine, 2024-01, Vol.21 (2), p.90-116

2024

Link zum Volltext

Verfügbarkeit prüfen

Effects of Tadalafil Treatment on Erectile Function Recovery Following Bilateral Nerve-sparing Radical Prostatectomy: A Randomised Placebo-controlled Study (REACTT)

European urology, 2014-03, Vol.65 (3), p.587-596

2014

Link zum Volltext

Verfügbarkeit prüfen

Targeted therapies in pulmonary arterial hypertension

Pharmacology & therapeutics (Oxford), 2014-02, Vol.141 (2), p.172-191

2014

Link zum Volltext

Verfügbarkeit prüfen

Intracavernosal OnabotulinumtoxinA Exerts a Synergistic Pro-Erectile Effect When Combined With Sildenafil in Spontaneously Hypertensive Rats

Journal of sexual medicine, 2022-06, Vol.19 (6), p.899-906

2022

Link zum Volltext

Verfügbarkeit prüfen

No clinically relevant pharmacokinetic and safety interactions of ambrisentan in combination with tadalafil in healthy volunteers

Journal of pharmaceutical sciences, 2009-12, Vol.98 (12), p.4962-4974

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.967

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.772)
Mit Volltextzugriff
(2.441)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.479)
Life Sciences & Biomedicine
(2.424)
Humans
(1.680)
Animals
(1.537)
Male
(1.432)
Phosphodiesterase Inhibitors - Pharmacology
(1.036)
Biological And Medical Sciences
(939)
3',5'-Cyclic-Amp Phosphodiesterases - Antagonists & Inhibitors
(836)
Pharmacology & Pharmacy
(829)
Medical Sciences
(799)
Cyclic Nucleotide Phosphodiesterases, Type 4
(711)
Cyclic Nucleotide Phosphodiesterases, Type 5
(629)
Rats
(615)
Phosphodiesterase Inhibitors - Therapeutic Use
(509)
Pharmacology. Drug Treatments
(507)
Sildenafil Citrate
(499)
Erectile Dysfunction
(467)
Erectile Dysfunction - Drug Therapy
(460)
Urology & Nephrology
(422)
3',5'-Cyclic-Amp Phosphodiesterases - Metabolism
(420)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

A review of analytical methods for the determination of four new phosphodiesterase type 5 inhibitors in biological samples and pharmaceutical preparations

Effects of obstructive sleep apnea and its treatment over the erectile function： a systematic review

Twelve-Month Efficacy and Safety of Low-Intensity Shockwave Therapy for Erectile Dysfunction in Patients Who Do Not Respond to Phosphodiesterase Type 5 Inhibitors

A meta-regression evaluating the effectiveness and prognostic factors of oral phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction

The NO/cGMP/PKG pathway in platelets: The therapeutic potential of PDE5 inhibitors in platelet disorders

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Successful treatment of pulmonary hypertension following hematopoietic stem cell transplant with a single oral tadalafil: a case report

Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction

Demographics and sexual characteristics of sex-enhancing medication users: Study of a web-based cross-sectional sample of sexually active men

Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons

Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015)

Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

A Systematic Review of the Association Between Erectile Dysfunction and Cardiovascular Disease

Management of Pulmonary Arterial Hypertension

Sexual life of Japanese patients with erectile dysfunction taking phosphodiesterase type 5 inhibitors: An Internet survey using the Psychological and Interpersonal Relationship Scales-Short Form questionnaire

Management of Benign Prostatic Hyperplasia

Comparative Effectiveness and Safety of Oral Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction: A Systematic Review and Network Meta-analysis

The Mechanism of Action of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia

Pharmacokinetics and Safety of Ambrisentan in Combination With Sildenafil in Healthy Volunteers

Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health

Effects of Tadalafil Treatment on Erectile Function Recovery Following Bilateral Nerve-sparing Radical Prostatectomy: A Randomised Placebo-controlled Study (REACTT)

Targeted therapies in pulmonary arterial hypertension

Intracavernosal OnabotulinumtoxinA Exerts a Synergistic Pro-Erectile Effect When Combined With Sildenafil in Spontaneously Hypertensive Rats

No clinically relevant pharmacokinetic and safety interactions of ambrisentan in combination with tadalafil in healthy volunteers

Suchergebnisse filtern